Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease

Weiwei Yu(Wenzhou University), Yining Huang(Peking University), Haiqiang Jin(Peking University)

Clinical Science

January 1, 2021

10.1042/cs20200844

Cited by 73

Related Papers

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

|The Lancet|2019|271

Optimal achieved blood pressure in acute intracerebral hemorrhage

|Neurology|2015|136

NAD+ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis

|Neuron|2023|95

New insights into targeting mitochondria in ischemic injury

|APOPTOSIS|2021|86

A Study on the Pathogenesis of Vascular Cognitive Impairment and Dementia: The Chronic Cerebral Hypoperfusion Hypothesis

|Journal of Clinical Medicine|2022|64